NCT02182518View on ClinicalTrials.gov

Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

July 31, 2001

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Epinastine

DRUG

Pseudoephedrine

DRUG

Placebo

Placebo during run-in period

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY